Default company panoramic image
F4a91c1a eefe 4809 9c12 d712c695fba2

Anubis Bio Corp

Anubis Bio Corp harnesses passive immunity to rapidly resolve bacterial and viral canine diarrhea infections without antibiotics.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Orlando, FL, USA
  • Currency USD
  • Founded June 2018
  • Employees 3
  • Incorporation Type C-corp
  • Website anubisbio.com

Company Summary

Anubis Bio Corp harnesses passive immunity to resolve canine diarrhea overnight without antibiotics. Over 60 million U.S. households count 90 million dogs as family members... and deal with 270 million diarrhea episodes each year. DoggyStat is faster and more effective than existing treatments. The Company is raising capital to expand market traction and B2B revenue, targeting partnering/sale to a major pet health products company.

Advisors

Previous Investors